Stubbs et al - TMAO and CV Outcomes in EVOLVE_CJASN.pdf (541.32 kB)
Download file

Stubbs et al - TMAO and CV Outcomes in EVOLVE_CJASN.pdf

Download (541.32 kB)
journal contribution
posted on 14.03.2019, 17:33 by Jason Stubbs, Margaret Stedman, Sai Liu, Jin Long, Yoko Franchetti, Raymond West III, Alex Prokopienko, Jonathan Mahnken, Glenn Chertow, Tom Nolin
The data demonstrates that baseline levels of TMAO, a circulating compound derived from byproducts of intestinal bacteria, do not predict cardiovascular endpoints in patients with end-stage kidney disease.

History

Grant ID

15GRNT25700231